Rice Hall James & Associates’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $494K | Buy |
109,604
+5,962
| +6% | +$26.9K | 0.03% | 220 |
|
|
2025
Q1 | $459K | Sell |
103,642
-4,907
| -5% | -$21.7K | 0.03% | 224 |
|
|
2024
Q4 | $850K | Sell |
108,549
-135
| -0.1% | -$1.06K | 0.05% | 207 |
|
|
2024
Q3 | $1.43M | Buy |
108,684
+18,949
| +21% | +$249K | 0.08% | 193 |
|
|
2024
Q2 | $1.08M | Buy |
89,735
+3,589
| +4% | +$43.4K | 0.07% | 206 |
|
|
2024
Q1 | $1.4M | Buy |
86,146
+633
| +0.7% | +$10.3K | 0.08% | 196 |
|
|
2023
Q4 | $583K | Sell |
85,513
-5,736
| -6% | -$39.1K | 0.03% | 238 |
|
|
2023
Q3 | $497K | Sell |
91,249
-1,773
| -2% | -$9.66K | 0.03% | 239 |
|
|
2023
Q2 | $632K | Buy |
93,022
+3,542
| +4% | +$24.1K | 0.04% | 236 |
|
|
2023
Q1 | $448K | Buy |
89,480
+2,390
| +3% | +$12K | 0.03% | 246 |
|
|
2022
Q4 | $425K | Sell |
87,090
-3,575
| -4% | -$17.4K | 0.02% | 249 |
|
|
2022
Q3 | $1.31M | Sell |
90,665
-1,233
| -1% | -$17.8K | 0.08% | 221 |
|
|
2022
Q2 | $1.39M | Buy |
91,898
+1,523
| +2% | +$23K | 0.07% | 223 |
|
|
2022
Q1 | $1.07M | Buy |
90,375
+5,980
| +7% | +$71.1K | 0.04% | 239 |
|
|
2021
Q4 | $1.37M | Sell |
84,395
-14,896
| -15% | -$241K | 0.05% | 231 |
|
|
2021
Q3 | $2.83M | Buy |
99,291
+2,517
| +3% | +$71.8K | 0.1% | 152 |
|
|
2021
Q2 | $3.27M | Sell |
96,774
-4,254
| -4% | -$144K | 0.12% | 131 |
|
|
2021
Q1 | $3.06M | Buy |
101,028
+34
| +0% | +$1.03K | 0.1% | 144 |
|
|
2020
Q4 | $5M | Buy |
100,994
+6,427
| +7% | +$318K | 0.18% | 102 |
|
|
2020
Q3 | $3.63M | Buy |
94,567
+30,241
| +47% | +$1.16M | 0.15% | 116 |
|
|
2020
Q2 | $2.78M | Buy |
64,326
+698
| +1% | +$30.2K | 0.12% | 129 |
|
|
2020
Q1 | $1.66M | Buy |
63,628
+24,062
| +61% | +$628K | 0.09% | 155 |
|
|
2019
Q4 | $1.24M | Buy |
+39,566
| New | +$1.24M | 0.04% | 221 |
|